Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Extreme morphological adaptations to accommodate large teeth in fish jaws. by Nick Peoples (21593888)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Phylogenetic tree of <i>Anaplasma ovis</i> based on the partial <i>msp4</i> gene sequences available in GenBank. by Sumaira Sumaira (21453523)

Effects of ABZ on the viability of <i>M. corti.</i> by Inés Guarnaschelli (18102211)

Microtubule organization in the tegument of <i>M. corti.</i> by Inés Guarnaschelli (18102211)

Fold change in clone size for large clones after ART. by Marco Garcia Noceda (22250847)

“…<p>Here we show the distribution of ratios of clone size at two and four years after ART initiation and clone size at one year after ART initiation, specifically for large clones (<i>n</i> > 1000 at one year after ART). …”

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically si... by Oswaldo Maillard (20660661)

S1 File - by Zsófia Tróznai (19923854)

“…Measurements of body size, body composition (InBody 720), and bone age were performed in all players who were selected to participate in the selection program (<i>n</i> = 264) (mean±sd age: 13.1±0.6 years) and in a sample of not-selected players (<i>n</i> = 266) (mean±sd age: 13.2±0.6 years). …”

Distribution of population at final time (left) and change in mean MSI at final time (right) from simulations across 1000 parameter sets when weevils are absent (red) and with weev... by Alexandra M. Campbell (3284094)

Localization of tegument and muscle markers of <i>M. corti.</i> by Inés Guarnaschelli (18102211)

Plots of FEV₁ (upper left), FVC (upper right), TLC (lower left) and TLCO (lower right) values expressed in % pred. (<i>y</i>-axis) against <i>z</i>-scores (<i>x</i>-axis... by Piotr W. Boros (21446186)

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Moran’s I value, Z value and P value of CCD-GFEE. by Dalai Ma (17847101)

“…Within them, the CCD of Chengdu is the highest, Chongqing has achieved the largest stage leap. (4) The global Moran’s I consistently remained positive and exhibited a tendency of initially rising and subsequently falling, indicating that the spatial aggregation effect of CCD-GFEE first increased and then decreased. (5) The CCD-GFEE driving factors are examined using the spatial econometric model, and it has been observed that the impact of population size and government intervention on CCD-GFEE is negative, while the impact of industrial structure, technological progress and economic level on the coupling and coordination of CCD-GFEE is positive. …”

Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation. by Sarah E. Copeland (13951506)

“…(H-I) 1 week of 6 mg/kg dox feed is sufficient to induce mitotic defects indicative of CIN in colons of 10–27 week old HA-MAD1 mice. …”

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)